Post-Marketing Safety Surveillance: Incorporation of a Test for Trends

被引：0
|
作者：
Kellier-Steele, Nicole [1 ]
Thompson, E. Alan [1 ]
Crowe, Brenda [1 ]
Hornbuckle, Kenneth [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2017年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
177
引用
收藏
页码：109 / 110
页数：2
相关论文
共 50 条
  • [1] Post-marketing device safety surveillance
    Vidi, Venkatesan D.
    Matheny, Michael E.
    Resnic, Frederic S.
    [J]. CONTEMPORARY CLINICAL TRIALS, 2011, 32 (03) : 307 - 308
  • [2] Post-marketing surveillance of the safety of levofloxacin in Japan
    Yamaguchi, Hiroki
    Kawai, Hitomi
    Matsumoto, Takuyuki
    Yokoyama, Hiroo
    Nakayasu, Toshio
    Komiya, Masahiro
    Shimada, Jingoro
    [J]. CHEMOTHERAPY, 2007, 53 (02) : 85 - 103
  • [3] POST-MARKETING SURVEILLANCE
    ROBSON, RH
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (03) : 404 - 404
  • [4] POST-MARKETING SURVEILLANCE
    SULLMAN, SF
    [J]. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1979, 72 (01) : 65 - 66
  • [5] POST-MARKETING SURVEILLANCE
    CULLITON, BJ
    WATERFALL, WK
    [J]. BRITISH MEDICAL JOURNAL, 1980, 280 (6224): : 1175 - 1176
  • [6] Post-marketing safety surveillance of the rotavirus vaccine in India
    Kang, Gagandeep
    Lakhkar, Anand
    Bhamare, Chetanraj
    Dharmadhikari, Abhijeet
    Narwadkar, Jyoti
    Kanujia, Arti
    Desai, Sajjad
    Gunale, Bhagwat
    Poonawalla, Cyrus S.
    Kulkarni, Prasad S.
    [J]. VACCINE: X, 2023, 15
  • [7] Fluvoxamine: Safety profile in extensive post-marketing surveillance
    Buchberger, R
    Wagner, W
    [J]. PHARMACOPSYCHIATRY, 2002, 35 (03) : 101 - 108
  • [8] POST-MARKETING SURVEILLANCE OF DRUGS
    LAWSON, DH
    [J]. BRITISH MEDICAL JOURNAL, 1979, 2 (6189): : 546 - 546
  • [9] Post-marketing surveillance of sertindole
    Toumi, M
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2002, 6 : S33 - S35
  • [10] Post-marketing surveillance of buprenorphine
    Ray, R
    Pal, H
    Kumar, R
    Maulick, P
    Mangla, R
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (09) : 615 - 619
12345